New implant aims to stop sleep apnea in its tracks

NCT ID NCT06556693

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 37 times

Summary

This study is testing a new device called the remedē Dual Channel System for people with severe sleep apnea. The device is implanted in the body and uses mild electrical stimulation to keep the airway open during sleep. The study will enroll 40 participants to see if the device is safe and can improve breathing. It is an early-stage feasibility study, so the main goals are to check safety and see if the device works as intended.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SLEEP APNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Insomnia and Sleep Institute of Arizona LLC

    RECRUITING

    Scottsdale, Arizona, 85255, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The Ohio State University

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact Email: •••••@•••••

    Contact

  • The University of Michigan Health-West

    RECRUITING

    Wyoming, Michigan, 49519, United States

    Contact Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

implantable dual channel stimulation device

What this could lead to

If successful, this device could offer a new treatment option for people with severe sleep apnea, potentially improving their breathing and sleep quality.

What could go wrong

This is an early feasibility study with only 40 participants, so results may not apply to everyone. The device requires surgery to implant, which carries risks like infection or nerve injury.

Conditions

The condition(s) this trial relates to.

sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.